Skip to main content
. Author manuscript; available in PMC: 2016 Aug 5.
Published in final edited form as: Am J Clin Pathol. 2012 Apr;137(4):665–670. doi: 10.1309/AJCP3FEPX5BEEKGX

Table 2.

Means (SD) for the Nine Parameters in Each of the Five Groups

BL CD10+ DLBCL P for BL vs CD10+ DLBCL* CD10− DLBCL Follicular Lymphoma Follicular Hyperplasia
FSC-H 121,182 (12,390) 134,204 (14,927) .005 145,859 (22,917) 89,926 (9,092) 104,337 (7,814)
SSC-H 35,945 (9,379) 39,166 (11,533) .367 40,733 (9,548) 23,003 (6,577) 36,139 (2,415)
CD20 19,753 (8,146) 29,844 (23,042) .145 13,225 (12,149) 15,677 (15,423) 19,805 (2,056)
CD10 9,269 (3,314) 5,162 (3,202) .029 532 (252) 7,744 (6,984) 1,631 (192)
CD38 26,671 (7,469) 20,689 (15,818) .282 3,155 (1,874) 4,373 (2,532) 33,275 (3,229)
CD43 2,356 (1,162) 1,657 (1,178) .029 1,639 (1,267) 414 (234) 383 (144)
CD79b 1,603 (1,212) 3,273 (2,585) .016 1,838 (1,716) 1,332 (1,213) 4,973 (1,051)
CD71 4,094 (4,936) 2,333 (2,706) .054 6,953 (4,195) 154 (67) 1,770 (658)
%CD71 69 (11) 53 (17) .020 57 (22) 3 (5) 29 (4)

BL, Burkitt lymphoma; DLBCL, diffuse large B-cell lymphoma; FSC-H, forward scatter height; SSC-H, side scatter height.

*

Student t test.